Member Info for Bazzaman

Interim results are on Tuesday 12th.

Https://www.investorschronicle.co.uk/ideas/2023/09/07/sylvania-is-overdue-a-re-rating/

GLA

Great presentation, Jaco excited about the future and pleased with overall performance. Next couple of years could be very interesting.

GLA

Https://www.investegate.co.uk/announcement/rns/tekcapital--tek/microsalt-files-new-patent-to-improve-baked-goods/7740395

Https://www.investegate.co.uk/announcement/rns/sylvania-platinum-ltd-di---slp/annual-financial-report/7740564

GLA

Venn

https://twitter.com/VennLifeScience/status/1699355325432775009

GLA

Includes an 18minute Directors talk by JS.

GLA

Https://twitter.com/PoolbegPharma/status/1699340202198614078

GLA

It's impossible to beat the shorters until they decide to stop. Once a month update from Shaun clearly isn't enough and Newmont have him well gagged. Lots of news to come in the next few months as is known but in the meantime the slippery downward trend will continue. Not sure where the bottom is but happy to hold to await the news. Will we ever get back to the 30p days? Who knows.

GLA

From their RNS last December which changed the accounting period, Publication of unaudited accounts for the 6 month period to 30 June 2023, no later than 30 September 2023.

Numbers seems to be what the market is waiting for before any sustained upward trend, although on Friday we get the published version of the IC with their latest update on TEK & Bell.

GLA

Https://twitter.com/tekcapital/status/1699041689946796386

Both the Nautica Powered by Lucyd line and its Lucyd Safety smart eyewear line are expected to be launched in Q4 2023. The Eddie Bauer and Reebok Powered by Lucyd lines are expected to launch in early Q1 2024.

Lucy SP up 4.73% today

GLA

Nice update on Acne, seems a certainty to me. Chewing gum would be a great solution for the teenage world.

GLA

Https://www.investorschronicle.co.uk/ideas/2023/09/01/profit-from-medtech-growth-with-this-undervalued-stock/

GLA

Full video to come, teaser from POLB.

https://twitter.com/PoolbegPharma/status/1697127076820623848

GLA

OK this was their update in 2022.

As part of the opening of a new specialised volunteer recruitment facility in London, the Whitechapel quarantine clinic and the Queen Mary’s Bioenterprises Centre (“QMB”) clinic will both be exclusively dedicated to conducting human challenge studies going forward. The space at QMB currently providing volunteer screening will be converted into further quarantine bedrooms. As such, the Company’s QMB facility will expand to 31 beds, adding to the Whitechapel Clinic’s 19 beds and the Plumbers Row Facility’s 12; in total the Company’s bed count will reach 62. These new facilities offer an opportunity to the Company to expand the scope of the business to offer Phase I and Phase II vaccine field trials, PK (pharmacokinetics) studies, bridging studies, and patient trials (as opposed to healthy volunteer human challenge trials) as part of large international multi-centre studies which do not require a quarantine setting.

The increase looks like from 31 to 50 by moving to CW.

GLA

I stand corrected the 24 was the initial bed capacity before the Whitechapel expansion which I think added another 12 beds.

Current bed capacity is 24, new facility will be expanded to 50 with option to add another 20 making it possibly 70 in total. No idea where 120 comes from.

GLA

Mo updating on Vox.

https://www.voxmarkets.co.uk/articles/q-a-with-hvivo-s-ceo-mo-khan-65a101d

GLA

Great RNS, will POLB be moving with them? I guess so as the old facility will be closing.

GLA

Here's another Twitter from POLB on AI.

https://twitter.com/PoolbegPharma/status/1694227973317013590

GLA